Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.35 USD | +0.39% |
|
-4.86% | -0.83% |
06-18 | EQT Weighing Sale of Consumer Health Firm Karo for More Than $2.1 Billion: Bloomberg | MT |
06-14 | EQT Corporation Redeems All of its Outstanding 6.125% Senior Notes Due 2025 | CI |
Evolution of the average Target Price on EQT Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering EQT Corporation
Jefferies & Co. | |
Tudor Pickering Holt & Co. | |
Evercore ISI | |
Wells Fargo Securities | |
Mizuho Securities | |
Siebert Williams Shank | |
BMO Capital | |
Scotiabank | |
UBS | |
Piper Sandler | |
JPMorgan Chase | |
Truist Securities | |
Stephens Inc. | |
Morgan Stanley | |
Bernstein | |
Goldman Sachs | |
BofA Securities | |
RBC Capital Markets | |
Citigroup | |
Wolfe Research | |
Credit Suisse |
EPS Revisions
- Stock Market
- Equities
- EQT Stock
- Consensus EQT Corporation